
Factors Affecting Response to Bacillus Calmette-Guérin Plus Interferon for Urothelial Carcinoma in Situ
Keywords: واکسن BCG; urinary bladder; urothelium; carcinoma in situ; BCG vaccine; interferonsBCG, bacillus Calmette-Guérin; BCG-N, BCG naïve; BCG-F, BCG failure; CIS, carcinoma in situ; IFN, interferon; NMIBC, nonmuscle invasive bladder cancer